Warren, R.; Blauvelt, A.; Bagel, J.; Papp, K.; Yamauchi, P.; Armstrong, A.; Langley, R.; Vanvoorden, V.; De Cuyper, D.; Peterson, L.; Cross, N.; Reich, K. Bimekizumab Efficacy and Safety Versus Adalimumab in Patients With Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE). J of Skin 2021, 5, s15.